EP Patent

EP3909569A1 — Methods of administering amantadine compositions

Assigned to Adamas Pharmaceuticals Inc · Expires 2021-11-17 · 4y expired

What this patent protects

Methods of administration of amantadine to improve movement disorders are described, as well as compositions suitable therefor.

USPTO Abstract

Methods of administration of amantadine to improve movement disorders are described, as well as compositions suitable therefor.

Drugs covered by this patent

amantadine-hydrochloride (AMANTADINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3909569A1
Jurisdiction: EP
Classification: —
Expires: 2021-11-17
Drug substance claim: No
Drug product claim: No
Assignee: Adamas Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.